{"id":"https://openalex.org/W2201132173","doi":"https://doi.org/10.1700/1578.17230","title":"Prolonged disease stability with trabectedin in two monorenal patients with retroperitoneal sarcoma.","display_name":"Prolonged disease stability with trabectedin in two monorenal patients with retroperitoneal sarcoma.","publication_year":2014,"publication_date":"2014-05-01","ids":{"openalex":"https://openalex.org/W2201132173","doi":"https://doi.org/10.1700/1578.17230","mag":"2201132173","pmid":"https://pubmed.ncbi.nlm.nih.gov/25076252"},"language":"en","primary_location":{"id":"pmid:25076252","doi":"https://doi.org/10.1700/1578.17230","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25076252","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tumori","raw_type":"Case Reports"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041736696","display_name":"Francesca Bruder","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesca Bruder","raw_affiliation_strings":["Oncologico Businco Hospital, Cagliari, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncologico Businco Hospital, Cagliari, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052761235","display_name":"Daniela Massa","orcid":"https://orcid.org/0000-0002-9711-1895","observed_orcids":["https://orcid.org/0000-0002-9711-1895"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniela Massa","raw_affiliation_strings":["Oncologico Businco Hospital, Cagliari, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncologico Businco Hospital, Cagliari, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055827780","display_name":"Michela Barca","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michela Barca","raw_affiliation_strings":["Oncologico Businco Hospital, Cagliari, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncologico Businco Hospital, Cagliari, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054123997","display_name":"Viviana Contu","orcid":"https://orcid.org/0009-0001-7774-365X","observed_orcids":["https://orcid.org/0009-0001-7774-365X"]},"institutions":[{"id":"https://openalex.org/I4210097265","display_name":"Azienda Ospedaliero Universitaria San Giovanni Battista","ror":"https://ror.org/00nrtez23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097265"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Viviana Contu","raw_affiliation_strings":["ASO San Giovanni Battista, Molinette Hospital, Turin, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ASO San Giovanni Battista, Molinette Hospital, Turin, Italy","institution_ids":["https://openalex.org/I4210097265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057001950","display_name":"Mario Airoldi","orcid":"https://orcid.org/0000-0002-1202-9973","observed_orcids":["https://orcid.org/0000-0002-1202-9973"]},"institutions":[{"id":"https://openalex.org/I4210097265","display_name":"Azienda Ospedaliero Universitaria San Giovanni Battista","ror":"https://ror.org/00nrtez23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097265"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mario Airoldi","raw_affiliation_strings":["ASO San Giovanni Battista, Molinette Hospital, Turin, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ASO San Giovanni Battista, Molinette Hospital, Turin, Italy","institution_ids":["https://openalex.org/I4210097265"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083485827","display_name":"A. Crova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097265","display_name":"Azienda Ospedaliero Universitaria San Giovanni Battista","ror":"https://ror.org/00nrtez23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097265"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alice Crova","raw_affiliation_strings":["ASO San Giovanni Battista, Molinette Hospital, Turin, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ASO San Giovanni Battista, Molinette Hospital, Turin, Italy","institution_ids":["https://openalex.org/I4210097265"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1638,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.57449235,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"100","issue":"3","first_page":"e63","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trabectedin","display_name":"trabectedin","score":1.0},{"id":"https://openalex.org/keywords/retroperitoneal-sarcoma","display_name":"retroperitoneal sarcoma","score":0.9599999785423279},{"id":"https://openalex.org/keywords/soft-tissue-sarcoma","display_name":"soft tissue sarcoma","score":0.9599999785423279},{"id":"https://openalex.org/keywords/stable-disease","display_name":"stable disease","score":0.7170000076293945},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.8040000200271606},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.722000002861023},{"id":"https://openalex.org/keywords/supportive-care","display_name":"supportive care","score":0.6899999976158142}],"concepts":[{"id":"https://openalex.org/C2780752271","wikidata":"https://www.wikidata.org/wiki/Q2637746","display_name":"Trabectedin","level":4,"score":0.9956656694412231},{"id":"https://openalex.org/C2778629024","wikidata":"https://www.wikidata.org/wiki/Q720020","display_name":"Soft tissue sarcoma","level":3,"score":0.7912293672561646},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.774124801158905},{"id":"https://openalex.org/C2777506904","wikidata":"https://www.wikidata.org/wiki/Q418560","display_name":"Ifosfamide","level":4,"score":0.6995784044265747},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.674371600151062},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6741759777069092},{"id":"https://openalex.org/C136948725","wikidata":"https://www.wikidata.org/wiki/Q1458306","display_name":"Soft tissue","level":2,"score":0.5325609445571899},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4766151010990143},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43936651945114136},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.34527361392974854},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3451969027519226},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.25355061888694763},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.23997879028320312},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000077606","descriptor_name":"Trabectedin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004149","descriptor_name":"Dioxoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004149","descriptor_name":"Dioxoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004149","descriptor_name":"Dioxoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D007890","descriptor_name":"Leiomyosarcoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007890","descriptor_name":"Leiomyosarcoma","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D008080","descriptor_name":"Liposarcoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008080","descriptor_name":"Liposarcoma","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009392","descriptor_name":"Nephrectomy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012186","descriptor_name":"Retroperitoneal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012186","descriptor_name":"Retroperitoneal Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D012186","descriptor_name":"Retroperitoneal Neoplasms","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D014057","descriptor_name":"Tomography, X-Ray Computed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018943","descriptor_name":"Anthracyclines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D044005","descriptor_name":"Tetrahydroisoquinolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D044005","descriptor_name":"Tetrahydroisoquinolines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D044005","descriptor_name":"Tetrahydroisoquinolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:25076252","doi":"https://doi.org/10.1700/1578.17230","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25076252","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tumori","raw_type":"Case Reports"},{"id":"mag:2201132173","doi":"https://doi.org/10.1700/1578.17230","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25076252","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2110046829","https://openalex.org/W1980350936","https://openalex.org/W1995622704","https://openalex.org/W2891961657","https://openalex.org/W2279293741","https://openalex.org/W2559784911","https://openalex.org/W2402849500","https://openalex.org/W2179832015","https://openalex.org/W1653100773","https://openalex.org/W1986145063"],"abstract_inverted_index":{"Soft":[0],"tissue":[1,22,77,96],"sarcomas":[2,78,97],"constitute":[3],"a":[4,49,112],"heterogeneous":[5],"group":[6],"of":[7,9,20,35,51,56,72,81,90,107,119,152],"tumors":[8,37],"mesenchymal":[10],"origin:":[11],"at":[12],"present,":[13],"more":[14],"than":[15],"50":[16],"separate":[17],"histological":[18],"subtypes":[19],"soft":[21,76,95],"sarcoma":[23,114],"have":[24,29,98],"been":[25,30,67,99],"listed.":[26],"Although":[27],"there":[28,46],"advances":[31],"in":[32,93],"the":[33,42,54,70,86,105,137,149],"understanding":[34],"these":[36],"and":[38,58,83,88,128],"their":[39],"treatment":[40,71],"over":[41],"past":[43],"few":[44],"years,":[45],"is":[47,146],"still":[48],"lack":[50],"consensus":[52],"on":[53],"standard":[55],"care,":[57],"new":[59],"therapeutic":[60],"options":[61],"are":[62],"eagerly":[63],"awaited.":[64],"Trabectedin":[65],"has":[66],"approved":[68],"for":[69],"patients":[73,110,138],"with":[74,111,121],"advanced":[75],"after":[79],"failure":[80],"anthracyclines":[82],"ifosfamide.":[84],"However,":[85],"effectiveness":[87],"tolerability":[89],"this":[91],"agent":[92],"retroperitoneal":[94,113],"poorly":[100],"characterized.":[101],"Here":[102],"we":[103],"report":[104],"cases":[106],"two":[108],"monorenal":[109],"who":[115],"achieved":[116],"prolonged":[117],"stabilization":[118],"disease":[120],"trabectedin.":[122,153],"Trabectedin-associated":[123],"toxicities":[124],"were":[125,129],"generally":[126],"mild":[127],"successfully":[130],"managed":[131],"by":[132],"supportive":[133],"care.":[134],"Of":[135],"note,":[136],"did":[139],"not":[140],"experience":[141],"clinically":[142],"relevant":[143],"myelosuppression,":[144],"which":[145],"currently":[147],"considered":[148],"limiting":[150],"toxicity":[151]},"counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}